Phosphatidylinositol 3-kinase Contributes to Erk1/Erk2 MAP Kinase Activation Associated with Hepatocyte Growth Factor-induced Cell Scattering
about
Interactions between PTEN and receptor tyrosine kinase pathways and their implications for glioma therapyTranscriptional gene expression profiles of HGF/SF-met signaling pathway in colorectal carcinoma.The ERK1/2-hepatocyte nuclear factor 4alpha axis regulates human ABCC6 gene expression in hepatocytes.miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway.Modulation of c-Met signaling and cellular sensitivity to radiation: potential implications for therapyThe Hepatocyte Growth Factor (HGF)/Met Axis: A Neglected Target in the Treatment of Chronic Myeloproliferative Neoplasms?Targeting the hepatocyte growth factor/mesenchymal epithelial transition pathway in gastric cancer: biological rationale and clinical applications.Gene of the month: HGF.Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges.Endothelial PAS domain-containing protein 1 confers TKI-resistance by mediating EGFR and MET pathways in non-small cell lung cancer cells.Benzyl isothiocyanate inhibits basal and hepatocyte growth factor-stimulated migration of breast cancer cells.MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.Autocrine activation of the hepatocyte growth factor receptor/met tyrosine kinase induces tumor cell motility by regulating pseudopodial protrusion.Ganglioside GD1a inhibits HGF-induced motility and scattering of cancer cells through suppression of tyrosine phosphorylation of c-Met.Glypican-1 regulates myoblast response to HGF via Met in a lipid raft-dependent mechanism: effect on migration of skeletal muscle precursor cellsThe Rho/Rho-kinase and the phosphatidylinositol 3-kinase pathways are essential for spontaneous locomotion of Walker 256 carcinosarcoma cells.c-Met and Other Cell Surface Molecules: Interaction, Activation and Functional Consequences.MiR-335 inhibits migration of breast cancer cells through targeting oncoprotein c-Met.
P2860
Q30437740-9E3592C2-C59D-4F1B-84E1-3A677F53552EQ33188158-C1ED2170-E44D-4012-B4BA-A9592A28ABCEQ34003799-75FD7B10-FA79-4303-99CF-C1EC594BA302Q34191243-1D6CE36C-98E4-4886-A479-5C77F702D5A7Q36828371-EA9F4BF7-1441-4E37-A5C4-5CC9BA74E119Q38239580-92312312-1FD0-400C-8534-88DB7546BEB9Q38263575-1243F9D8-13BD-4941-9AC8-63681833D07AQ38806819-F5BE86FE-2FC4-42E4-A5F1-106A7DA845FDQ38856729-DF5676AB-0A07-4501-85CC-A971602717EBQ38892107-969B3DFB-EE43-4B58-8585-20AB85A2411AQ39479495-247265A3-5E31-4D47-A64C-59D8BB829C83Q40147018-64C6829C-92FD-4AFD-9CFA-1E7A9A73EE41Q40698534-32C6A707-FB41-4DC9-B887-8313F6BCA8E0Q40763145-A0825339-E9A9-4B95-B5D5-9D34A86A7502Q41953959-54033195-5DCB-4550-9996-C5C18AB5DE14Q43557974-0F831879-8556-40D3-8180-F2199A373ADAQ50985108-65631684-AB17-4B29-9FE9-A0635089698AQ55069380-E88902AD-8646-4A1E-9794-6C944C77CE7D
P2860
Phosphatidylinositol 3-kinase Contributes to Erk1/Erk2 MAP Kinase Activation Associated with Hepatocyte Growth Factor-induced Cell Scattering
description
im Dezember 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 December 1999
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 1999
@uk
name
Phosphatidylinositol 3-kinase ...... Factor-induced Cell Scattering
@en
Phosphatidylinositol 3-kinase ...... Factor-induced Cell Scattering
@nl
type
label
Phosphatidylinositol 3-kinase ...... Factor-induced Cell Scattering
@en
Phosphatidylinositol 3-kinase ...... Factor-induced Cell Scattering
@nl
prefLabel
Phosphatidylinositol 3-kinase ...... Factor-induced Cell Scattering
@en
Phosphatidylinositol 3-kinase ...... Factor-induced Cell Scattering
@nl
P2093
P1433
P1476
Phosphatidylinositol 3-kinase ...... factor-induced cell scattering
@en
P2093
P304
P356
10.1016/S0898-6568(99)00060-1
P577
1999-12-01T00:00:00Z